Hisamitsu Pharmaceutical Co., Inc. (4530.T)
JPY 4437.0
(2.05%)
JPY 4437.0
(2.05%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 65.8 Billion JPY | 7.7% |
| 2022 | 61.09 Billion JPY | 0.61% |
| 2021 | 60.73 Billion JPY | 3.81% |
| 2020 | 58.5 Billion JPY | -9.83% |
| 2019 | 64.87 Billion JPY | -2.3% |
| 2018 | 66.4 Billion JPY | 0.86% |
| 2017 | 65.83 Billion JPY | -0.94% |
| 2016 | 66.46 Billion JPY | -12.32% |
| 2015 | 75.8 Billion JPY | -4.23% |
| 2014 | 79.15 Billion JPY | 4.09% |
| 2013 | 76.04 Billion JPY | 15.59% |
| 2012 | 65.78 Billion JPY | 1.1% |
| 2011 | 65.07 Billion JPY | 6.16% |
| 2010 | 61.29 Billion JPY | 4.61% |
| 2009 | 58.58 Billion JPY | 12.16% |
| 2008 | 52.23 Billion JPY | -3.06% |
| 2007 | 53.88 Billion JPY | 6.17% |
| 2006 | 50.75 Billion JPY | 1.4% |
| 2005 | 50.05 Billion JPY | 34.11% |
| 2004 | 37.32 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 18.74 Billion JPY | 12.56% |
| 2024 Q1 | 16.65 Billion JPY | -14.47% |
| 2023 Q1 | 14.35 Billion JPY | -14.67% |
| 2023 Q2 | 15.89 Billion JPY | 10.71% |
| 2023 Q4 | 19.47 Billion JPY | 21.1% |
| 2023 FY | 65.8 Billion JPY | 7.7% |
| 2023 Q3 | 16.08 Billion JPY | 1.17% |
| 2022 Q1 | 14.22 Billion JPY | -10.68% |
| 2022 FY | 61.09 Billion JPY | 0.61% |
| 2022 Q2 | 15.32 Billion JPY | 7.73% |
| 2022 Q4 | 16.82 Billion JPY | 14.26% |
| 2022 Q3 | 14.72 Billion JPY | -3.91% |
| 2021 Q4 | 15.92 Billion JPY | 5.59% |
| 2021 Q1 | 14.47 Billion JPY | -9.22% |
| 2021 Q2 | 15.24 Billion JPY | 5.28% |
| 2021 FY | 60.73 Billion JPY | 3.81% |
| 2021 Q3 | 15.08 Billion JPY | -1.06% |
| 2020 Q3 | 14.71 Billion JPY | 7.42% |
| 2020 FY | 58.5 Billion JPY | -9.83% |
| 2020 Q1 | 14.13 Billion JPY | -24.71% |
| 2020 Q2 | 13.7 Billion JPY | -3.05% |
| 2020 Q4 | 15.95 Billion JPY | 8.37% |
| 2019 Q3 | 15.78 Billion JPY | 6.91% |
| 2019 FY | 64.87 Billion JPY | -2.3% |
| 2019 Q1 | 15.55 Billion JPY | -13.33% |
| 2019 Q2 | 14.76 Billion JPY | -5.05% |
| 2019 Q4 | 18.76 Billion JPY | 18.89% |
| 2018 Q3 | 16.43 Billion JPY | -0.29% |
| 2018 FY | 66.4 Billion JPY | 0.86% |
| 2018 Q1 | 15.54 Billion JPY | -9.83% |
| 2018 Q4 | 17.94 Billion JPY | 9.18% |
| 2018 Q2 | 16.48 Billion JPY | 6.03% |
| 2017 Q2 | 16.26 Billion JPY | -4.27% |
| 2017 Q1 | 16.98 Billion JPY | -2.98% |
| 2017 FY | 65.83 Billion JPY | -0.94% |
| 2017 Q4 | 17.23 Billion JPY | 12.31% |
| 2017 Q3 | 15.34 Billion JPY | -5.61% |
| 2016 Q1 | 18.87 Billion JPY | -2.1% |
| 2016 Q4 | 17.5 Billion JPY | 28.96% |
| 2016 FY | 66.46 Billion JPY | -12.32% |
| 2016 Q3 | 13.57 Billion JPY | -17.76% |
| 2016 Q2 | 16.5 Billion JPY | -12.52% |
| 2015 Q2 | 19.22 Billion JPY | -1.08% |
| 2015 Q4 | 19.27 Billion JPY | 7.82% |
| 2015 Q3 | 17.87 Billion JPY | -6.99% |
| 2015 FY | 75.8 Billion JPY | -4.23% |
| 2015 Q1 | 19.43 Billion JPY | -6.61% |
| 2014 FY | 79.15 Billion JPY | 4.09% |
| 2014 Q4 | 20.8 Billion JPY | 6.4% |
| 2014 Q3 | 19.55 Billion JPY | -0.04% |
| 2014 Q2 | 19.56 Billion JPY | 1.7% |
| 2014 Q1 | 19.23 Billion JPY | -6.23% |
| 2013 Q3 | 18.62 Billion JPY | -0.63% |
| 2013 Q4 | 20.51 Billion JPY | 10.1% |
| 2013 FY | 76.04 Billion JPY | 15.59% |
| 2013 Q1 | 18.15 Billion JPY | 3.37% |
| 2013 Q2 | 18.74 Billion JPY | 3.28% |
| 2012 Q3 | 15.55 Billion JPY | -1.81% |
| 2012 Q2 | 15.84 Billion JPY | -5.83% |
| 2012 FY | 65.78 Billion JPY | 1.1% |
| 2012 Q4 | 17.56 Billion JPY | 12.88% |
| 2012 Q1 | 16.82 Billion JPY | 0.66% |
| 2011 Q2 | 17.59 Billion JPY | 15.0% |
| 2011 Q3 | 15.45 Billion JPY | -12.15% |
| 2011 Q4 | 16.71 Billion JPY | 8.13% |
| 2011 FY | 65.07 Billion JPY | 6.16% |
| 2011 Q1 | 15.3 Billion JPY | -5.66% |
| 2010 Q2 | 16.15 Billion JPY | 9.53% |
| 2010 Q1 | 14.74 Billion JPY | -12.24% |
| 2010 Q4 | 16.21 Billion JPY | 14.42% |
| 2010 FY | 61.29 Billion JPY | 4.61% |
| 2010 Q3 | 14.17 Billion JPY | -12.23% |
| 2009 Q2 | 15.08 Billion JPY | 12.76% |
| 2009 Q1 | 13.37 Billion JPY | 0.0% |
| 2009 FY | 58.58 Billion JPY | 12.16% |
| 2009 Q4 | 16.8 Billion JPY | 26.0% |
| 2009 Q3 | 13.33 Billion JPY | -11.56% |
| 2008 FY | 52.23 Billion JPY | -3.06% |
| 2007 FY | 53.88 Billion JPY | 6.17% |
| 2006 FY | 50.75 Billion JPY | 1.4% |
| 2005 FY | 50.05 Billion JPY | 34.11% |
| 2004 FY | 37.32 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | -50.792% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 97.487% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 87.863% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 66.703% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -1661.18% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | -0.264% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -126.707% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 87.654% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -1145.816% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | -42.227% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -469.584% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -699.368% |
| Tsumura & Co. | 48.8 Billion JPY | -34.844% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | -97.467% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -236.817% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | -3.245% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -419.902% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | -62.621% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | -44.959% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -1482.968% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -1006.88% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -1159.966% |
| MedRx Co., Ltd | 959 Million JPY | -6761.731% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -2189.847% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -4358.266% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -2675.761% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -172.311% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | -85.714% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -8850.721% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 34.075% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -2815.181% |